The S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) is expected to open lower on Monday, with shares of RCG Corporation Ltd (ASX: RCG) and Catapult Group International Ltd (ASX: CAT) in focus.
Here’s a quick recap of global markets:
- FTSE 100 (UK): down 0.5%
- DAX (Germany): down 0.1%
- CAC 40 (France): down 0.1%
- Dow Jones (USA): down 0.2%
- NASDAQ (USA): flat
In London, the blue chip index (FTSE 100) ended firmly lower on Friday as banks weighed on the market. FTSE-listed shares of BHP Billiton Limited (ASX: BHP) and Rio Tinto Limited (ASX: RIO) ended 1.9% and 1.1% higher, respectively.
In the U.S, markets ended lower following a disappointing first quarter GDP reading.
Closer to home, the ASX 200 is expected to open slightly lower today, following global markets.
In company-specific news, RCG Corporation, the owner of The Athlete’s Foot and more, today reported a market downgrade saying sales have fallen short of management’s expectations. Concerningly, the RCG share price has fallen 24% over the past month.
Shares of technology business Catapult Group International have entered a trading halt, pending a capital raising.
Cimic Group Ltd (ASX: CIM) announced that its subsidiary Leighton Asia has been awarded a $436 million contract in Hong Kong.
Quintis Ltd (ASX: QIN), formally TFS Corporation, reported, “good progress” at Santalis, its pharmaceutical subsidiary.
Finally, analysts at Credit Suisse raised their ResMed Inc. (CHESS) (ASX: RMD) price target 2.6% to $9.70 while UBS analysts cut their AWE Limited (ASX: AWE) price target 4.8% to $0.60, according to Dow Jones Newswires.